GlobeNewswire by notified

Millicom Announces Early Participation Results of and Increases the Maximum Acceptance Amount for the Exchange Offer


Millicom Announces Early ParticipationResults of and Increases the Maximum Acceptance Amount for the Exchange Offer

Luxembourg, September 22, 2021 – In connection with its previously-announced offer to exchange (the “Exchange Offer”) its outstanding 6.625% Senior Notes due 20261 (the “2026 Existing Notes” or “Old Notes”) for 4.500% Senior Notes due 2031 (the “New Notes”), Millicom International Cellular S.A. (the “Company”) (NASDAQ U.S.: TIGO, Nasdaq Stockholm: TIGO_SDB) announces the results as of the Early Participation Date (as defined below) and increases the Maximum Acceptance Amount (as defined below) for the Exchange Offer to accept all 2026 Existing Notes that were validly tendered and not validly withdrawn by the Early Participation Date (as defined below).

Early Participation Date Results

The Early Participation Date with respect to the Exchange Offer occurred at 5:00 PM, New York City time, on September 21, 2021 (such time and date, the “Early Participation Date”). According to information provided by D.F. King, the information and exchange agent for the Exchange Offer (the “Information and Exchange Agent”), US$335,716,000 aggregate original principal amount of the Old Notes (representing US$302,144,400‬ aggregate outstanding principal amount of Old Notes, after applying the “Pool Factor” (as defined below)) were validly tendered and were not validly withdrawn prior to or at the Early Participation Date, resulting in the oversubscription of the Exchange Offer, as discussed below.

As discussed in the offering memorandum related to the Exchange Offer, dated September 8, 2021 (the “Offering Memorandum”), in February 2021, the Company redeemed 10%, or US$50 million, of the then-outstanding aggregate principal amount of the Old Notes, which amount was recorded by Euroclear, Clearstream and DTC as a prepayment of principal. In accordance with the procedures of Euroclear, Clearstream and DTC, book-entry positions of the Old Notes reflect the aggregate original issued principal amount and a pool factor of 90% (the “Pool Factor”). The Old Notes trade with the Pool Factor, which means the percentage of the US$500,000,000 aggregate original principal amount of the Old Notes that remains outstanding after the impact of the Company’s optional redemption of US$50 million in Old Notes in February 2021 (such redemption, the “Partial Redemption”), which equals 90%. References to the “original” principal amount of the Old Notes refer to the US$500 million aggregate original principal amount of the Old Notes issued in October 2018, or portions thereof, without giving effect to the Partial Redemption or the Pool Factor.

Holders of the Old Notes validly tendered and not validly withdrawn by the Early Participation Date are eligible to receive $1,018.12 in principal amount of New Notes per US$1,000 in outstanding principal amount on the Old Notes (after giving effect to the Pool Factor) validly tendered and accepted for exchange pursuant to the terms of the Offering Memorandum. The principal amount of New Notes to be issued in exchange for each US$1,000 outstanding principal amount of the Old Notes (after giving effect to the Pool Factor) was calculated by dividing (x) $1,053.75 (the “Total Exchange Price”), of which US$31.05 constitutes an early participation payment (the “Early Participation Payment”), by (y) $1,035.00 (the “Price of New Notes”).

Concurrently with the Early Participation Date, the Withdrawal Date (as defined in the Offering Memorandum) has also occurred. As a result, any Old Notes validly tendered on or after the date of the Early Participation Date may not be withdrawn, except in certain limited circumstances where additional withdrawal rights are required by law.

Issuance of New Notesand increase of Maximum Acceptance Amount

Our obligation to accept Old Notes validly tendered and not validly withdrawn was capped at US$335,000,000 in aggregate original principal amount, before application of the Pool Factor (the “Maximum Acceptance Amount”). The aggregate original principal amount of all of the validly tendered and not validly withdrawn Old Notes exceeded the Maximum Acceptance Amount, resulting in the oversubscription of the Exchange Offer. As a result, the Company has determined to increase the aggregate original principal amount of Old Notes it will accept for tender to US$335,716,000 (the “New Maximum Acceptance Amount”). Accordingly, Old Notes in an aggregate original principal amount of US$335,716,000, which have been validly tendered and not validly withdrawn by the Early Participation Date, have been accepted by the Company and, on September 24, 2021 (the “Early Exchange Date”), the Company expects to issue approximately US$307.5 million in aggregate principal amount of New Notes in exchange for such Old Notes. Any other holders who validly tender Old Notes after the Early Participation Date will not have any of their Old Notes accepted in the Exchange Offer.

Cash will be paid in lieu of any fractional entitlement of less than $1,000.00 in principal amount of New Notes that are not issued due to rounding. The amount of cash paid in lieu will be equal to the principal amount of any fractional entitlement of New Notes multiplied by the Price of New Notes expressed as a percentage (103.5%).

Holders of Old Notes that are accepted in the Exchange Offer will also receive a cash payment equal to the accrued and unpaid interest on their 2026 Existing Notes accepted for exchange from the last applicable interest payment date up to but excluding the Early Exchange Date, less the accrued and unpaid interest on the New Notes from April 27, 2021 (the last date on which interest on the existing 4.500% Senior Notes due 2031 has been paid) to the Early Exchange Date.

Further Information

The Exchange Offer is being made only to holders of 2026 Existing Notes who have certified, by submitting an instruction to the clearing system, that such holder has represented to the Company that it is (1)(a) a “qualified institutional buyer,” or “QIB,” as defined in Rule 144A under the U.S. Securities Act of 1933, as amended (the “Securities Act”) and under applicable state securities laws; or (b) a “non-US Person” (as defined in Regulation S under the Securities Act), and (2)(a) if located or resident in any Member State of the European Economic Area, holders of 2026 Existing Notes who are persons other than “retail investors” (for these purposes, a retail investor means a person who is one (or more) of: (i) a retail client as defined in point (11) of Article 4(1) of Directive 2014/65/EU (as amended, “MiFID II”); (ii) a customer within the meaning of Directive (EU) 2016/97, as amended, where that customer would not qualify as a professional client as defined in point (10) of Article 4(1) of MiFID II; or (iii) not a “qualified investor” as defined in Regulation (EU) 2017/1129, as amended); and (b) if located or resident in the United Kingdom, holders of 2026 Existing Notes who are persons other than “retail investors” (for these purposes, a retail investor means a person who is one (or more) of: (i) a retail client, as defined in point (8) of Article 2 of Regulation (EU) No 2017/565 as it forms part of domestic law by virtue of the European Union (Withdrawal) Act 2018 (“EUWA”); (ii) a customer within the meaning of the provisions of the Financial Services and Markets Act 2000 (the “FSMA”) and any rules or regulations made under the FSMA to implement Directive (EU) 2016/97, where that customer would not qualify as a professional client, as defined in point (8) of Article 2(1) of Regulation (EU) No 600/2014 as it forms part of domestic law by virtue of the EUWA; or (iii) not a qualified investor as defined in Article 2 of Regulation (EU) 2017/1129 as it forms part of domestic law by virtue of the EUWA) (such holders, collectively, the “Eligible Holders”).

Old Notes that were not exchanged in the Exchange Offer will remain outstanding. If the Company consummates the Exchange Offer, the trading market for your outstanding Old Notes may be significantly more limited. For a discussion of this and other risks, see Risk Factors in the Offering Memorandum.

This press release is qualified in its entirety by the Offering Memorandum.

None of the Company, its board of directors, the Dealer Managers (as defined in the Offering Memorandum), the Information and Exchange Agent or the Trustee (as defined in the Offering Memorandum) with respect to the Old Notes or any of their respective affiliates is making any recommendation as to whether Eligible Holders should exchange their Old Notes in the Exchange Offer. Holders must make their own decision as to whether to participate in the Exchange Offer, and, if so, the original principal amount of the Old Notes to exchange.

None of the delivery of this announcement, the Offering Memorandum or any exchange pursuant to the Exchange Offer shall under any circumstances create any implication that the information contained in this announcement or the Offering Memorandum is correct as of any time subsequent to the date hereof or thereof or that there has been no change in the information set forth herein or therein or in the Company’s affairs since the date hereof or thereof.

This press release is for informational purposes only and does not constitute an offer or an invitation to participate in the Exchange Offer. The Exchange Offer is being made pursuant to the Offering Memorandum, copies of which were delivered to holders of the Old Notes, and which set forth the complete terms and conditions of the Exchange Offer. Eligible Holders are urged to read the Offering Memorandum carefully before making any decision with respect to their Old Notes. The Exchange Offer is not being made to, nor will the Company accept exchanges of Old Notes from, holders in any jurisdiction in which it is unlawful to make such an offer.

D.F. King has been appointed as the Information and Exchange Agent for the Exchange Offer. You may contact the Information and Exchange Agent by calling +44 20 7920 9700 (in London), +1 212 269 5550 (in New York), +1 (800) 431-9646 (toll free) or via e-mail to Holders wishing to access the Offering Memorandum should visit the Exchange Offer website ( and complete the online Eligibility Certification form.

This press release is not an offer to sell or a solicitation of an offer to buy any security. The Exchange Offer is being made solely to such persons and in such jurisdictions as are permitted under applicable law.

The New Notes have not been and will not be registered under the Securities Act and may not be offered or sold in the United States absent registration or an applicable exemption from the registration requirements. The New Notes are being issued only to Eligible Holders.

Important Information – Cautionary Statement About Forward-Looking Statements

This press release contains certain forward-looking statements concerning our intentions, including those in respect of the Exchange Offer, beliefs or current expectations regarding our future financial results, plans, liquidity, prospects, growth, strategy and profitability, as well as the general economic conditions of the industries and countries in which we operate. Forward-looking statements include statements concerning our plans, objectives, goals, strategies, future events, future sales or performance, capital expenditures, financing needs, plans or intentions relating to acquisitions, our competitive strengths and weaknesses, our business strategy and the trends we anticipate in the industries and the economic, political and legal environments in which we operate and other information that is not historical information. Many such forward-looking statements can be identified by the use of forward-looking words such as “anticipate,” “believe,” “could,” “expect,” “should,” “plan,” “intend,” “estimate” and “potential,” among others.

Such forward-looking statements are only our current expectations and are based on our management’s beliefs and assumptions and on information currently available to our management. Such statements are subject to risks and uncertainties, and actual results may differ materially from those expressed or implied in the forward-looking statements as a result of various factors, including those described in Millicom’s annual report on Form 20-F for the year ended December 31, 2020 as well as other uncertainties and events, especially in light of the political, economic, social and legal environments in which we operate. These forward-looking statements are expressly qualified in their entirety by this cautionary statement. The Company disclaims any obligation to update any forward-looking statements contained herein to reflect events or circumstances after the date of such statements, or to reflect the occurrence of anticipated or unanticipated events, except as required by law.


For further information, please contact

Vivian Kobeh, Director, Corporate Communications


Yocasta Valdez, Group Manager, Digital Media & Communications

Michel Morin, VP, Investor Relations


Sarah Inmon, Director, Investor Relations


About Millicom
Millicom (NASDAQ U.S.: TIGO, Nasdaq Stockholm: TIGO_SDB) is a leading provider of fixed and mobile services dedicated to emerging markets in Latin America and Africa. Millicom sets the pace when it comes to providing high- speed broadband and innovation around The Digital Lifestyle® services through its principal brand, TIGO. As of December 31, 2020, Millicom operating subsidiaries and joint ventures employed more than 21,000 people and provided mobile services to approximately 55 million customers, with a cable footprint of more than 12 million homes passed. Founded in 1990, Millicom International Cellular S.A. is headquartered in Luxembourg.

1 ISIN/Common Code Nos. XS1894610119 and 189461011 (Regulation S Notes) and CUSIP/ISIN Nos. 600814AP20 and US600814AP20 (Rule 144A Notes).


To view this piece of content from, please give your consent at the top of this page.
To view this piece of content from, please give your consent at the top of this page.

About GlobeNewswire by notified

GlobeNewswire by notified
GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York

GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Subscribe to releases from GlobeNewswire by notified

Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from GlobeNewswire by notified

REC Silicon – Settlement of claims under indemnity loans18.10.2021 22:54:59 CEST | Press release

Moses Lake, WA, October 18, 2021: Reference is made to previous announcements from REC Silicon ASA ("REC") of 20 December 2019 and 18 November 2020 about claims from Nordea of NOK 150 million under certain indemnity arrangements. REC and Nordea have now entered into a settlement agreement pursuant to which Nordea releases all claims against REC, against payment of NOK 95,000,000, of which approx. NOK 32 million is settled through an existing escrow account of REC with Nordea, and the balance is to be settled in one payment of approx. NOK 63 million by the end of February 2022. For further information, please contact: James A. May II, Chief Financial Officer Phone: +1 509 989 1023 Email: Nils O. Kjerstad, IR Contact Phone: +47 9135 6659 Email: About REC Silicon REC Silicon is a leading producer of advanced silicon materials, delivering high-purity polysilicon and silicon gas to the solar and electronics industries worldwide. We combine 30 y

Inventiva announces the presentation of five scientific abstracts at the AASLD The Liver Meeting™ 202118.10.2021 22:00:00 CEST | Press release

Four poster presentations add to the evidence of the beneficial effects of lanifibranor therapy on key components of NASH, following further sub-analyses of Inventiva’s NATIVE Phase IIb clinical trial resultsThe fifth poster presentation demonstrates that lanifibranor improves NASH, fibrosis and diastolic dysfunction in a hamster model of diet-induced NASH and diastolic dysfunction Daix (France), Long Island City (New York, United States), October 18, 2021 – Inventiva (Euronext Paris and Nasdaq: IVA), a clinical-stage biopharmaceutical company focused on the development of oral small molecule therapies for the treatment of non-alcoholic steatohepatitis (NASH), mucopolysaccharidoses (MPS) and other diseases with significant unmet medical needs, today announced that five scientific abstracts have been selected for poster presentations during the upcoming The Liver Meeting™ 2021, organized by the American Association for the Study of Liver Diseases (AASLD) on November 12-15, 2021. The fir

Bast Fibre Technologies acquires German textile processing facility to fulfil customer demand18.10.2021 18:12:39 CEST | Press release

VICTORIA, British Columbia, Oct. 18, 2021 (GLOBE NEWSWIRE) -- Bast Fibre Technologies (BFT), a manufacturer of specialty natural fibres for the global nonwoven industry, announces the acquisition of Faser Veredlung Tönisvorst (FVT), an ISO 9001 certified textile processing facility located in Tönisvorst Germany. This purchase enables BFT to immediately increase capacity to meet customer demand for its sustainable bast fibres and provides a firm platform for expansion and continued growth. With over twenty years of fibre processing experience, FVT is located within close proximity to major European centres for bast crop cultivation and nonwoven fabric construction. This transaction follows BFT’s strategy of establishing low carbon, regional supply chains by sourcing, producing, and selling within specific regions. The facility is currently being expanded with the installation of specialty refining equipment specifically designed to optimize natural bast fibres for use in a variety of no

Lenny Clarhäll ställer ut i Bror Hjorths Hus18.10.2021 17:20:13 CEST | Pressemelding

Uppsala, Oct. 18, 2021 (GLOBE NEWSWIRE) -- Lenny Clarhäll - Profiler 23 okt - 28 nov 2021 Bror Hjorths Hus, Uppsala Utställningen visar främst skulpturer och målningar från de senaste tio åren. Lenny Clarhäll (född 1938) har varit bildkonstnär i sextio år och har en rad viktiga utställningar och betydande offentliga verk bakom sig. Läsandet, inte minst sentida poesi, och musik, har satt djupa spår i hans sökande efter abstraktion i ett sparsmakat bildspråk. Ett antal bilder har rubriken Ljudet av aska och är en direkt följd av detta. Mötet med ryska ikoner har satt avtryck i strikt formmässiga målningar med byggnader och arkitektur som grundläggande motiv i utställningen. De skulpturer som visas har samlingsnamnet Profiler. Detta är berättelser om möten med andra konstnärer som har haft stor betydelse för hans utveckling, översatta i trä och brons. Utställning Profiler pågår 23 oktober-28 november 2021 på Bror Hjorths Hus i Uppsala. Utställningskommissarie är museets chef Tomas Järlide

trivago N.V.'s Third Quarter 2021 Earnings Release Scheduled for November 1, 202118.10.2021 15:30:00 CEST | Press release

DÜSSELDORF, GERMANY – October 18, 2021 - trivago N.V. (NASDAQ: TRVG) announced today that it will release its financial results for the third quarter for the period ended September 30, 2021 on Monday, November 1, 2021. On the same day, trivago N.V.'s management will conduct a webcast beginning at 1:15 PM CET / 8:15 AM EDT. These items will be available in the Investor Relations section of the company's website at A replay of the call is expected to be available for at least three months. About trivago N.V. trivago N.V. (NASDAQ: TRVG) is a global hotel and accommodation search platform. We are focused on reshaping the way travelers search for and compare different types of accommodations, such as hotels, vacation rentals and apartments, while enabling our advertisers to grow their businesses by providing them with access to a broad audience of travelers via our websites and apps. Our platform allows travelers to make informed decisions by personalizing their sea

Centessa Pharmaceuticals Subsidiary, Orexia Therapeutics, and Schrödinger Announce Collaboration to Discover Novel Orexin Receptor Agonists18.10.2021 14:00:00 CEST | Press release

~ Discovery efforts will focus on small molecules with differentiated clinical profiles to harness the broad potential of orexin agonism across different indications~ ~ First time Schrödinger is applying its computational platform in an orexin agonist setting enabled by Orexia’s structural biology capabilities ~ NEW YORK, BOSTON and LONDON, Oct. 18, 2021 (GLOBE NEWSWIRE) -- Schrödinger (Nasdaq: SDGR) and Centessa Pharmaceuticals plc (“Centessa”) (Nasdaq: CNTA), together with subsidiary Orexia Therapeutics (“Orexia”), today announced an exclusive collaboration focused on the discovery of novel therapeutics targeting the orexin-2 receptor (OX2R), which is known to play a role in a broad spectrum of sleep disorders including narcolepsy. The collaboration provides Orexia with substantial access to Schrödinger’s entire computational platform as well as Schrödinger’s extensive expertise in ultra-large-scale deployment of its technology. Orexia will leverage Schrödinger’s computational platfo

Saniona completes submission of manufacturing data for Tesomet capsules to U.S. FDA18.10.2021 14:00:00 CEST | Press release

PRESS RELEASE 18October 2021 Saniona (OMX: SANION), a clinical stage biopharmaceutical company focused on rare diseases, today announcedthat it has completed the submission of all information previously requested by the U.S. Food and Drug Administration (FDA) regarding its chemistry, manufacturing and controls (CMC) programfor Tesomet capsules. With this submission completed, Saniona expects to be able to initiate its Phase 2b clinical trials for Tesomet before the end of 2021, as planned. There are multiple potential advantages to offering Tesomet as a capsule rather than a tablet to people living with Prader-Willi syndrome or hypothalamic obesity. Some of these individuals have a tendency to chew tablets, which could disrupt the effectiveness of the fixed-dose combination of Tesomet’s active ingredients. The Tesomet capsules contain the two active ingredients as microspheres, which are expected to minimize the impact of chewing or biting. Additionally, capsules are generally easier t